More than half of all global deaths in 2010 were related to non-communicable diseases,
including obesity, cancers, diabetes, and cardiovascular illnesses. It has been suggested …

The incidence of obesity is rising worldwide at an alarming rate and is becoming a major
public health concern with incalculable social and economic costs. Studies have exposed …

Dietary polyphenols may exert their pharmacological effect via synergistic interactions with
multiple targets. Putative effects of polyphenols in the management of obesity should be …

The use of plant-derived polyphenols for the management of diseases has been under
debate in the last decades. Most studies have focused on the specific effects of polyphenols …

Identification of the links among flavonoid consumption, mitigation of oxidative stress and
improvement of disease in humans has significantly advanced in the last decades. This …

Growing evidence support that insulin resistance may occur as a severe problem due to
chronic energetic overfeeding and subsequent obesity. When an abundance of glucose and …

Type 2 diabetes (T2D) and obesity are known as important chronic diseases in the world. A
common mechanism of pathogenesis in both diseases is the dysregulation of the insulin …

Prevalence of obesity worldwide has reached pandemic proportions. Despite the increasing
evidence in the implication of phenolic compounds in obesity management, the real effect is …

The aim of this review, a summary of the putative biological actions of flavonoids, was to
obtain a further understanding of the reported beneficial health effects of these substances …

Phenolic compounds are widely present in the plant kingdom. Many epidemiological studies
have indicated that consumption of some plant‐derived foodstuffs with high phenolic content …